George Church
"Dr. George Church is the founding core faculty member and platform lead for synthetic biology at the Wyss Institute; professor of genetics at Harvard Medical School; and professor of health sciences and technology at Harvard and MIT. As the lead scientist of the Wyss Institute’s synthetic biology platform, George oversees the directed evolution of molecules, polymers, and whole genomes to create new tools with applications in regenerative medicine and bioenergy. Among his recent work at the Wyss Institute is the development of a technology for synthesizing whole genes, and potentially whole gene circuits, that is faster, more accurate, and significantly less expensive than current methods.
"Dr. Church is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry and biomedicine. In 1984, he developed the first direct genomic sequencing method, which resulted in the first commercial genome sequence (the human pathogen, H. pylori). He helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. Dr. Church invented the broadly applied concepts of molecular multiplexing and tags, homologous recombination methods, and array DNA synthesizers. His many innovations have been the basis for a number of companies including Joule Unlimited, Inc. (solar fuels); LS9, Inc. (bio-petroleum); and Knome (full human genome sequencing)." [1]
- Scientific Advisory Board, eGenesis
- Advisory council, Revive & Restore
- Founder, Open Humans Foundation [2]
- Founder, Nebula Genomics
- Founder, Editas Medicine
- Cofounder, Rejuvenate Bio
- Business and Science Advisor, Odin [3]
Resources and articles
Related Sourcewatch
- Jeffrey Epstein VI Foundation
- Flagship Ventures
- CRISPR Therapeutics
- Intellia Therapeutics
- Synthego
- Casebia
- Personal Genome Project
